Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000936
Chunk: 68

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 68
---
 otherwise required by the
Staff or the SEC to reduce the number of Registrable Securities included in such initial Registration Statement, then the Company shall
reduce the number of Registrable Securities to be included in such initial Registration Statement (after consulting with the Investor
and its legal counsel as to the specific Registrable Securities to be removed therefrom) until such time as the Staff and the SEC shall
so permit such Registration Statement to become effective and be used as aforesaid. In the event of any reduction in Registrable Securities
pursuant to this paragraph, the Company shall file one or more New Registration Statements in accordance with until
such time as all Registrable Securities have been included in Registration Statements that have been declared effective and the prospectus
contained therein is available for use by the Investor. Notwithstanding any provision herein or in the Purchase Agreement to the contrary,
the Company’s obligations to register the Registrable Securities (and any related conditions to the Investor’s obligations)
shall be qualified as necessary to comport with any requirement of the SEC or the Staff as addressed in this .

e. . Any Registrable Security shall cease to be a “Registrable Security” at the earliest of the following: (i)
when a Registration Statement covering such Registrable Security becomes or has been declared effective by the SEC and such Registrable
Security has been sold or disposed pursuant to such effective Registration Statement, (ii) when such Registrable Security is held by the
Company or one of its subsidiaries, and (iii) the date that is the later of (A) the first (1) anniversary of the date of
termination of the Purchase Agreement in accordance with its terms and (B) the first (1) anniversary of the date of the last
sale of any Registrable Securities to the Investor pursuant to the Purchase Agreement.

| 3 |

3. .

With respect to the Registration
Statement and whenever any Registrable Securities are to be registered pursuant to , including on any New Registration
Statement, the Company shall use its commercially reasonable efforts to effect the registration of the Registrable Securities in accordance
with the intended method of disposition thereof and, pursuant thereto, the Company shall have the following obligations:

a. The
Company shall prepare and file with the SEC such amendments (including post-effective amendments) and supplements to any Registration
Statement and the prospectus used in connection with such Registration Statement, which prospectus is to be filed pursuant to Rule 424
promulgated under the Securities Act, as may be necessary to keep the Registration